****

A sudden alteration to the House GOP's extensive bill has stirred significant alarm among Obamacare insurers who had already determined their rates for 2026. Private insurers and state officials warn that this unexpected modification, if passed by the Senate, could bring chaos to the insurance markets.

The new policy mandates the resumption of certain federal payments to insurers that former President Donald Trump had canceled, on the condition that plans do not cover abortions. This stands in contrast to requirements in 12 states and the District of Columbia, where abortion coverage is mandatory. This change adds to the existing uncertainty related to eligibility changes and the expiration of ACA enhanced premium subsidies. According to one anonymous insurance executive, the combination of these factors could lead to a significant spike in premiums, endangering the stability of the Obamacare market.

Insurers in most states had proactively submitted two sets of rates for the 2026 plan year, accounting for the uncertainty of subsidy continuation initiated in 2021. However, the unexpected return of federal payments to insurers for reducing cost-sharing for low-income customers caught many off guard. Devon Trolley, executive director of Pennsylvania's Obamacare exchange, Pennie, highlighted the compounded effect of multiple cost increases and expressed concern over the minimal time available for thorough analysis before the fall open enrollment.

America's Health Insurance Plans (AHIP), the largest insurer trade group, also voiced concerns, fearing that the swift return of cost-sharing reduction (CSRs) payments would destabilize the market. According to AHIP spokesperson Tina Stow, Congress is expected to ensure access to affordable, quality health care, and failing to extend premium tax credits coupled with this new policy might lead to significant hikes in insurance premiums, affecting millions by 2026.

Some conservative experts, however, argue that the reintroduction of federal cost-sharing payments will benefit consumers by lowering premiums for often-used plans. Brian Blase, of the Paragon Health Institute, emphasized that the CSR appropriations provide a dual advantage by reducing both premiums and subsidies.

However, the House bill's ban on using these funds for plans that cover abortion accentuates the importance of "silver loading." This strategy, previously employed when Trump canceled CSR payments, involves insurers increasing premiums for specific plans to secure higher federal subsidies, indirectly compensating for lost cost-sharing payments. States like Colorado and Maryland, which mandate abortion coverage, might see premiums soar if they cannot leverage this loophole.

The Senate is now a focal point, with discussions around amendments to the House-passed bill becoming crucial. Key senators, including Josh Hawley, Lisa Murkowski, and Susan Collins, stand against the Medicaid cuts proposed by the House. With Senate Majority Leader John Thune needing a near-unanimous GOP vote to pass the megabill, intense negotiations are underway to secure the required support before the July 4 deadline.